Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted therapy for breast cancer in older patients.
Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Lago LD. Pondé N, et al. Among authors: lago ld. J Geriatr Oncol. 2020 Apr;11(3):380-388. doi: 10.1016/j.jgo.2019.05.012. Epub 2019 Jun 4. J Geriatr Oncol. 2020. PMID: 31171494 Review.
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.
Wildiers H, Meyskens T, Marréaud S, Lago LD, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Meulemans B, Sousa B, Poncet C, Brain E. Wildiers H, et al. Among authors: lago ld. Breast. 2022 Aug;64:100-111. doi: 10.1016/j.breast.2022.05.004. Epub 2022 May 20. Breast. 2022. PMID: 35636341 Free PMC article. Clinical Trial.
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Bonnefoi H, Piccart M, Bogaerts J, Mauriac L, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Blot E, Zaman K, Cufer T, Lortholary A, Lidbrink E, André S, Litière S, Lago LD, Becette V, Cameron DA, Bergh J, Iggo R; EORTC 10994/BIG 1-00 Study Investigators. Bonnefoi H, et al. Among authors: lago ld. Lancet Oncol. 2011 Jun;12(6):527-39. doi: 10.1016/S1470-2045(11)70094-8. Epub 2011 May 11. Lancet Oncol. 2011. PMID: 21570352 Free PMC article. Clinical Trial.
Anti-HER2 therapy for breast cancer in older patients.
Goldner M, Franzoi MA, Lago LD, Pondé N. Goldner M, et al. Among authors: lago ld. Future Oncol. 2020 Jul;16(19):1393-1407. doi: 10.2217/fon-2020-0036. Epub 2020 May 28. Future Oncol. 2020. PMID: 32462916 Review.
Old age: An extra risk for febrile neutropenia?
Klastersky J, Lago LD. Klastersky J, et al. Among authors: lago ld. J Geriatr Oncol. 2017 Mar;8(2):84-85. doi: 10.1016/j.jgo.2017.01.001. Epub 2017 Jan 24. J Geriatr Oncol. 2017. PMID: 28130010 No abstract available.
Current perspectives of epothilones in breast cancer.
Cardoso F, de Azambuja E, Lago LD. Cardoso F, et al. Among authors: lago ld. Eur J Cancer. 2008 Feb;44(3):341-52. doi: 10.1016/j.ejca.2007.11.019. Eur J Cancer. 2008. PMID: 18178426 Review.
16 results